Itziar Lamiquiz-Moneo

Dr. Itziar Lamiquiz-Moneo

Hospital Miguel Servet, Zaragoza, Spain
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Atherosclerosis
Verified
Journal Article
Open access
SPSofía Perez-Calahorra
Sofía Perez-Calahorra
MLMartin Laclaustra
Martin Laclaustra
VMVictoria Marco-Benedí
Victoria Marco-Benedí
ILItziar Lamiquiz-Moneo
Itziar Lamiquiz-Moneo
JPJuan Pedro-Botet
Juan Pedro-Botet
FCFernando Civeira
Fernando Civeira
The impact on heterozygous familial hypercholesterolemia (HeFH) health led by high-intensity lipid-lowering therapy (HILLT) is unknown, and the question remains if there is still an unacceptably high residual risk to justify treatment with new lipid-lowering drugs. This observational, retrospective, multicenter, national study in Spain, whose information was obtained from a national dyslipemia registry, was designed to establish the current prevalence of cardiovascular disease (CVD) in HeFH and to define the impact of HILLT on CVD in this population. Odds were estimated using several logistic regression models with progressive adjustment. 1958 HeFH, mean age 49.3 ± 14.3 years, were included in the analysis. At inclusion in the registry, 295 patients (15.1%) had suffered CVD and 164 (55.6%) had suffered the first event before the onset lipid-lowering treatment. Exposition to treatment associated more than ten times lower odds for CVD than in subjects naïve to treatment (OR 0.085, 95% CI 0.063-0.114, p < 0.001). A first CVD event after a mean treatment period of 9.1 ± 7.2 years occurred in 131 out of 1615 (8.1%) HeFH subjects, and 115 (87.8%) of them were on HILLT. Current prevalence of CVD among HeFH is one third of that reported before the statins era. Early initiation and prolonged lipid-lowering treatment was associated with a reduction in CVD. New cases of CVD, in spite of HILLT, appeared mostly among patients accumulating risk factors and probably they may be considered for further lipid-lowering drugs.

30 June 2022 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
RMRocío Mateo-Gallego
Rocío Mateo-Gallego
LMLoreto Madinaveitia-Nisarre
Loreto Madinaveitia-Nisarre
JGJaume Giné-Gonzalez
Jaume Giné-Gonzalez
ABAna María Bea
Ana María Bea
LGLydia Guerra-Torrecilla
Lydia Guerra-Torrecilla
ILItziar Lamiquiz-Moneo
Itziar Lamiquiz-Moneo

1 February 2020 in Clinical Nutrition
Verified
Journal Article
Open access
RMRocío Mateo-Gallego
Rocío Mateo-Gallego
SPSofía Pérez-Calahorra
Sofía Pérez-Calahorra
ILItziar Lamiquiz-Moneo
Itziar Lamiquiz-Moneo
VMVictoria Marco-Benedí
Victoria Marco-Benedí
ABAna M. Bea
Ana M. Bea
FCFernando Civeira
Fernando Civeira
The quality of carbohydrates has an essential role in nutritional management of type 2 diabetes mellitus (T2DM) because of its substantial impact on glucose homeostasis. Alcohol-free beer has beneficial bioactive components but it has a relatively high glycemic-index so its consumption is restricted in diabetic subjects. We aimed to explore the effect of an alcohol-free beer with modified carbohydrate composition almost completely eliminating maltose and adding isomaltulose (16.5 g/day) and a resistant maltodextrin (5.28 g/day) in comparison to a regular alcohol-free beer on glycemic control of diabetic subjects with overweight or obesity. We randomized 41 subjects into two groups: a) consumption of 66 cL/day of; regular alcohol-free beer for the first 10 weeks and 66 cL/day of alcohol-free beer with modified carbohydrate composition for the next 10 weeks; b) the same described intervention in opposite order. There was a washout period for 6-8 weeks between the two interventions. Participants were counseled to adhere to a healthy diet for cardiovascular health and to increase physical activity. Clinical, biochemical, anthropometric, lifestyle and satiety assessments were performed at the beginning and at the end of each period. Subjects showed significantly weight loss after the two ten weeks periods (-1.69 ± 3.21% and -1.77 ± 3.70% after experimental and regular alcohol-free beers, respectively, P = 0.881). Glucose and glycated hemoglobin did not significantly change after any period. Insulin concentrations and HOMA-IR significantly decreased (-11.1 [-21.3-4.64]% and -1.92 ± 32.8% respectively) after the intake of experimental alcohol-free beer but not after regular alcohol-free beer. Reductions remained statistically significant after adjusting for weight loss, energy intake, physical activity and intervention order. Subjects reported higher satiety scores after consuming experimental alcohol-free beer. An alcohol-free beer including the substitution of regular carbohydrates for low doses of isomaltulose and the addition of a resistant maltodextrin within meals led to an improvement in insulin resistance in subjects with T2DM and overweight or obesity. The clinical trial has been registered in ClinicalTrials.gov (Identifier: NCT03337828).

6 June 2023 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
MGMC Garza
MC Garza
SOS Olivan
S Olivan
EME Monleón
E Monleón
ACANA ISABEL CISNEROS-GIMENO
ANA ISABEL CISNEROS-GIMENO
AGA García-Barrios
A García-Barrios
ILItziar Lamiquiz-Moneo
Itziar Lamiquiz-Moneo
Background: Game-based learning (GBL) is effective for increasing participation, creativity, and student motivation. However, the discriminative value of GBL for knowledge acquisition has not yet been proven. The aim of this study is to assess the value of Kahoot! as a discriminative tool for formative assessment in medical education in two different subjects.Methods: A prospective experimental study was conducted on a sample of 173 students enrolled in neuroanatomy (2021–2022). One hundred twenty-five students individually completed the Kahoot! prior to the final exam. In addition, students enrolled in human histology during two academic courses were included in the study. The control group course (2018–2019) received a traditional teaching methodology (N = 211), while Kahoot! was implemented during 2020–2021 (N = 200). All students completed similar final exams for neuroanatomy and human histology based on theory tests and image exams.Results: The correlation between the Kahoot score and the final grade was analyzed for all students enrolled in neuroanatomy who completed both exercises. The correlation between the Kahoot exercise and the theory test, image exam and final grade was significantly positive in all cases (r = 0.334 p < 0.001, r = 0.278 p = 0.002 and r = 0.355 p < 0.001, respectively). Moreover, students who completed the Kahoot! exercise obtained significantly higher grades in all parts of the exam. Regarding human histology, the theory tests, image exams and final grades were significantly higher when using Kahoot! versus the “traditional” methodology (p < 0.001, p < 0.001 and p = 0.014, respectively).Conclusions: Our study demonstrates for the first time that Kahoot! can be used to improve and predict the final grade in medical education subjects.

10 October 2019 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Open access
ILItziar Lamiquiz-Moneo
Itziar Lamiquiz-Moneo
JGJaume Giné-González
Jaume Giné-González
SASonsoles Alisente
Sonsoles Alisente
ABAna M. Bea
Ana M. Bea
SPSofía Pérez-Calahorra
Sofía Pérez-Calahorra
RMRocío Mateo-Gallego
Rocío Mateo-Gallego
Dyslipidemia is a well-established modifiable cardiovascular risk. Although statins can reduce LDLc by 50–60%, less than 20% of patients with high risk of CVD achieve LDL targets. The aim of this systematic review is to evaluate the effect of the nutraceutical, bergamot (Citrus bergamia), on lipid parameters in humans. PubMed, Embase, Cochrane Library, and Google Scholar databases were searched for interventional and observational studies investigating the effect of bergamot on lipid profile in humans. This systematic review retrieved a total of 442 studies of which 12 articles fulfilled the eligibility criteria and were included in the qualitative synthesis. Based on data, 75% of studies showed a significant decrease in total cholesterol, triglycerides and LDLc. The decrease in total cholesterol varied from 12.3% to 31.3%, from 7.6% to 40.8% in LDLc and from 11.5% to 39.5% in triglycerides. Eight trials reported HDLc increase after intervention with bergamot. Overall, a dose-dependent and possible synergistic effect when administering with statins can be deducted from these trials. It is essential to point out that studies had heterogeneous designs and scientific quality of studies was quite limited. Promising findings reveal an alternative therapeutic option in dyslipidemia management with bergamot supplementation, especially in subjects with statins intolerance.

7 March 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
MGMª Carmen Garza García
Mª Carmen Garza García
SPSofía Pérez-Calahorra
Sofía Pérez-Calahorra
CRCarmen Rodrigo-Carbó
Carmen Rodrigo-Carbó
MSMaría Antonia Sánchez-Calavera
María Antonia Sánchez-Calavera
EJEstibaliz Jarauta
Estibaliz Jarauta
ILItziar Lamiquiz-Moneo
Itziar Lamiquiz-Moneo
Background: The Mediterranean Diet (MedDiet) is the dietary pattern par excellence for managing and preventing metabolic diseases, such as Type 2 Diabetes (T2DM). The MedDiet incorporates spices and aromatic herbs, which are abundant sources of bioactive compounds. The aim of this study was to analyze the effect of all aromatic herbs and spices included in the MedDiet, such as black cumin, clove, parsley, saffron, thyme, ginger, black pepper, rosemary, turmeric, basil, oregano, and cinnamon, on the glycemic profile in T2DM subjects. Methods: PubMed, Web of Science, and Scopus databases were searched for interventional studies investigating the effect of these aromatic herbs and spices on the glycemic profile in T2DM subjects. Results: This systematic review retrieved 6958 studies, of which 77 were included in the qualitative synthesis and 45 were included in the meta-analysis. Our results showed that cinnamon, turmeric, ginger, black cumin, and saffron significantly improved the fasting glucose levels in T2DM subjects. The most significant decreases in fasting glucose were achieved after supplementation with black cumin, followed by cinnamon and ginger, which achieved a decrease of between 27 and 17 mg/dL. Conclusions: Only ginger and black cumin reported a significant improvement in glycated hemoglobin, and only cinnamon and ginger showed a significant decrease in insulin.